We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 7,778 results
  1. Piezo2 Channel Upregulation is Involved in Mechanical Allodynia in CYP-Induced Cystitis Rats

    Mechanical sensing Piezo2 channel in primary sensory neurons has been shown contribute to mechanical allodynia in somatic chronic pain conditions....

    Lei Liu, Yan Zhao, ... Wendong Sun in Molecular Neurobiology
    Article Open access 25 May 2023
  2. Application of fused-grid-based CYP-Template systems for genotoxic substances to understand the metabolisms

    Understanding of metabolic processes is a key factor to evaluate biological effects of carcinogen and mutagens. Applicability of fused-grid Template*...

    Yasushi Yamazoe, Norie Murayama, ... Takashi Yamada in Genes and Environment
    Article Open access 07 August 2023
  3. A self-microemulsion enhances oral absorption of docetaxel by inhibiting P-glycoprotein and CYP metabolism

    Oral absorption of docetaxel was limited by drug efflux pump p-glycoprotein (P-gp) and cytochrome P450 enzyme (CYP 450). Therefore, co-loading agent...

    Le Tong, ZeYang Zhou, ... Chao Wu in Drug Delivery and Translational Research
    Article 14 December 2022
  4. Evaluation of Hydroxychloroquine as a Perpetrator on Cytochrome P450 (CYP) 3A and CYP2D6 Activity with Microdosed Probe Drugs in Healthy Volunteers

    Background and Objective

    Although polypharmacy is a particular challenge in daily rheumatological practice, clinical research on the effects of...

    Felicitas Stoll, Antje Blank, ... Walter E. Haefeli in European Journal of Drug Metabolism and Pharmacokinetics
    Article Open access 20 December 2023
  5. Prediction of CYP-mediated silybin A-losartan pharmacokinetic interactions using physiological based pharmacokinetic modeling

    The concomitant use of herbal products and synthetic drugs necessitates the assessment of their interaction potentials. The herbal hepatoprotective...

    Ayesha Tanveer, Khalid Hussain, ... Nadeem Irfan Bukhari in Journal of Pharmacokinetics and Pharmacodynamics
    Article 21 January 2022
  6. CYP Phenoty**

    Reference work entry 2022
  7. A cocktail probe approach to evaluate the effect of hormones on the expression and activity of CYP enzymes in human hepatocytes with conditions simulating late stage of pregnancy

    Purpose

    Pregnancy-mediated physiological and biochemical changes contribute to alterations in the pharmacokinetics of certain drugs. There is a...

    Ali Alshabi, Imam H. Shaik, ... Raman Venkataramanan in European Journal of Clinical Pharmacology
    Article 15 April 2023
  8. Inter-individual variation in chlorpyrifos toxicokinetics characterized by physiologically based kinetic (PBK) and Monte Carlo simulation comparing human liver microsome and Supersome cytochromes P450 (CYP)-specific kinetic data as model input

    The present study compares two approaches to evaluate the effects of inter-individual differences in the biotransformation of chlorpyrifos (CPF) on...

    Shensheng Zhao, Sebastiaan Wesseling, ... Marije Strikwold in Archives of Toxicology
    Article Open access 16 March 2022
  9. CYP Genoty**

    Reference work entry 2022
  10. CYP-associated drug–drug interactions: A mission accomplished?

    On the basis of official Finnish Medicines Authority (Fimea)-approved drug monographs, less than half of the approved small-molecule drugs between...

    Olavi Pelkonen, Jukka Hakkola, ... Miia Turpeinen in Archives of Toxicology
    Article 06 October 2020
  11. Cytochrome P450 (CYP)

    Reference work entry 2022
  12. Inhibition and induction of CYP enzymes in humans: an update

    The cytochrome P450 (CYP) enzyme family is the most important enzyme system catalyzing the phase 1 metabolism of pharmaceuticals and other...

    Jukka Hakkola, Janne Hukkanen, ... Olavi Pelkonen in Archives of Toxicology
    Article Open access 27 October 2020
  13. Geneesmiddeleninteracties via cytochroom P450 (CYP)

    Geneesmiddelen kunnen elkaars werking op farmacodynamische en farmacokinetische wijze beïnvloeden: in het eerste geval is er bijv. sprake van...
    J. M. A. Sitsen, H. Abdullah-Koolmees in Geneeskundig Jaarboek 2021
    Chapter 2021
  14. Differentiation of Cytochrome P450-Mediated from Non-CYP-Mediated Metabolism: Aldehyde Oxidase and Xanthine Oxidoreductase

    Aldehyde oxidase and xanthine oxidoreductase are part of the molybdo-flavo family of enzymes. They have become increasingly relevant in drug...
    Kirk D. Kozminski, Michael A. Zientek in Cytochrome P450
    Protocol 2021
  15. Circadian Clock and CYP Metabolism

    Cytochromes P450 (CYPs), a superfamily of hemoproteins, have monooxygenase activity and are involved in xenobiotic detoxification and lipid...
    Tianpeng Zhang, Fangjun Yu, ... Dong Dong in Circadian Pharmacokinetics
    Chapter 2020
  16. Circadian Clock and Non-CYP Phase I Metabolism

    Circadian rhythms in drug metabolism by non-CYP phase I enzymes (i.e., MAOs) have been recognized since 1970s. The profound effects of the circadian...
    Min Chen, Tianpeng Zhang, ... Baojian Wu in Circadian Pharmacokinetics
    Chapter 2020
  17. Effect of N-acetylcysteine on hair follicle changes in mouse model of cyclophosphamide-induced alopecia: histological and biochemical study

    Chemotherapy-induced alopecia (CIA) represents one of the most severe side effects of chemotherapy, which forces some patients to reject cancer...

    Yomna F. Hassan, Dalia A. Shabaan in Histochemistry and Cell Biology
    Article Open access 20 April 2024
  18. S-warfarin limited sampling strategy with a population pharmacokinetic approach to estimate exposure and cytochrome P450 (CYP) 2C9 activity in healthy adults

    Purpose

    S-warfarin is used to phenotype cytochrome P450 (CYP) 2C9 activity. This study evaluated S-warfarin limited sampling strategy with a...

    Lana Tran, Mina Nikanjam, ... Joseph D. Ma in European Journal of Clinical Pharmacology
    Article 23 March 2021
  19. The Use of Microdosing for In vivo Phenoty** of Cytochrome P450 Enzymes: Where Do We Stand? A Narrative Review

    Cytochrome P450 (CYP) enzymes play a central role in the elimination of approximately 80% of all clinically used drugs. Differences in CYP enzyme...

    Lisa T. van der Heijden, Frans L. Opdam, ... Alwin D. R. Huitema in European Journal of Drug Metabolism and Pharmacokinetics
    Article Open access 30 April 2024
Did you find what you were looking for? Share feedback.